[Transdermal buprenorphine and silent acute coronary syndrome].
M A
MA
Vidal
E
E
Calderón
A
A
Pernia
E
E
Calderón-Pla
L M
LM
Torres
D000279:Administration, Cutaneous; D000368:Aged; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D015906:Angioplasty, Balloon, Coronary; D018771:Arthralgia / Q000188:drug therapy* / Q000209:etiology; D002047:Buprenorphine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002637:Chest Pain; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D017202:Myocardial Ischemia / Q000150:complications; D015207:Osteoarthritis, Hip / Q000150:complications; D015607:Stents
D000701:Analgesics, Opioid; D002047:Buprenorphine